PatientsVille.com Logo

Lower and Ciprofloxacin

PatientsVille

Lower Symptoms and Causes

What is cholesterol?

Your body needs some cholesterol to work properly. But if you have too much in your blood, it can stick to the walls of your arteries and narrow or even block them. This puts you at risk for coronary artery disease and other heart diseases.

There are two main types of cholesterol. LDL is the "bad" cholesterol. A high LDL level leads to a buildup of cholesterol in your arteries. HDL is the "good" cholesterol. It carries cholesterol from other parts of your body back to your liver. Then your liver removes the cholesterol from your body.

There are steps that you can take to Lower your LDL (bad) cholesterol and raise your HDL (good) cholesterol. By keeping your cholesterol levels in range, you can Lower your risk of heart diseases.

What are the treatments for high cholesterol?

The main treatments for high cholesterol are lifestyle changes and medicines.

Lifestyle changes to Lower cholesterol

Heart-healthy lifestyle changes that can help you Lower or control your cholesterol include

  • Heart-healthy eating. A heart-healthy eating plan limits the amount of saturated and trans fats that you eat. It recommends that you eat and drink only enough calories to stay at a healthy weight and avoid weight gain. It encourages you to choose a variety of nutritious foods, including fruits, vegetables, whole grains, and lean meats. Examples of eating plans that can Lower your cholesterol include the Therapeutic Lifestyle Changes diet and the DASH eating plan.
  • Weight Management. If you are overweight, losing weight can help Lower your LDL (bad) cholesterol. This is especially important for people with metabolic syndrome. Metabolic syndrome is a group of risk factors that includes high triglyceride levels, low HDL (good) cholesterol levels, and being overweight with a large waist measurement (more than 40 inches for men and more than 35 inches for women).
  • Physical Activity. Everyone should get regular physical activity (30 minutes on most, if not all, days).
  • Managing stress. Research has shown that chronic stress can sometimes raise your LDL cholesterol and Lower your HDL cholesterol.
  • Quitting smoking.Quitting smoking can raise your HDL cholesterol. Since HDL helps to remove LDL cholesterol from your arteries, having more HDL can help to Lower your LDL cholesterol.
Medicines to Lower cholesterol

For some people, making lifestyle changes alone does not their Lower cholesterol enough. They may also need to take medicines. There are several types of cholesterol-Lowering drugs available. They work in different ways and can have different side effects. Talk to your health care provider about which medicine is right for you.

Even if you take medicines to Lower your cholesterol, you still need to continue with lifestyle changes.

Lipoprotein apheresis to Lower cholesterol

Familial hypercholesterolemia (FH) is an inherited form of high cholesterol. Some people who have FH may get a treatment called lipoprotein apheresis. This treatment uses a filtering machine to remove LDL cholesterol from the blood. Then the machine returns the rest of the blood back to the person.

Supplements to Lower cholesterol

Some companies sell supplements that they say can Lower cholesterol. Researchers have studied many of these supplements, including red yeast rice, flaxseed, and garlic. At this time, there isn't conclusive evidence that any of them are effective in Lowering cholesterol levels. Also, supplements may cause side effects and interactions with medicines. Always check with your health care provider before you take any supplements.

Check out the latest treatments for lower

lower treatment research studies

Ciprofloxacin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Ciprofloxacin Side Effects

Arthralgia (550)
Pain In Extremity (389)
Tendonitis (280)
Diarrhoea (274)
Pyrexia (260)
Renal Failure Acute (240)
Tendon Pain (237)
Dizziness (236)
Headache (234)
Anxiety (233)
Myalgia (229)
Nausea (225)
Pain (225)
Paraesthesia (219)
Insomnia (208)
Fatigue (204)
Rash (202)
Gait Disturbance (196)
Confusional State (187)
Tendon Rupture (174)
Asthenia (173)
Hypoaesthesia (168)
Pruritus (165)
Vomiting (163)
Dyspnoea (159)
Oedema Peripheral (147)
Muscular Weakness (140)
Muscle Spasms (132)
Abdominal Pain (129)
Neuropathy Peripheral (128)
Back Pain (127)
Burning Sensation (126)
International Normalised Ratio Increased (126)
Erythema (124)
Tendon Disorder (121)
Malaise (113)
Depression (112)
Feeling Abnormal (110)
Urticaria (109)
Musculoskeletal Pain (107)
Chest Pain (105)
Joint Swelling (104)
Convulsion (99)
Condition Aggravated (98)
Sepsis (94)
Agitation (94)
Tinnitus (93)
Abasia (93)
Palpitations (93)
Urinary Tract Infection (89)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I have been taking ciprofloxacina for an stomacal infection. It has worked well, I feel much better but I have experienced dizziness (a lot of dizziness).

side effects of ciprofloxacine on strocke patients

After a couple of days on Cipro, I started to have hallucinations. I remembered yellow dots and other figures. So bad that I had to change meds.

DOES CIPROFLOXACI CAUSE DEATH OR IT SOME RELATED ISSNESS

Effects of ciprofloxacin on CVA patients

Elderly patient with IT and massive mastoid sinusitis being treated with vancomycin/cipro IV duo. Side effects???

Hello, After three blower back operationsmy painis chronic, soI had the Medtronic lower back stimulator trialabout two months ago. The moment I got home from the hospital I laid down on the couch with pillows u

Heyyy

How long are cipro bags good for once removed from the outer wrap?

I am 17 years old and im taking ciprofloxacin for my kidney infection, and at first i thought i was just being silly but i started to see things and like now it is more intense.like things are there them gone and like untill recently it hasn't bother

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

63 yo man received Zostavax injection in the left upper arm 12/13/11. Developed painful blister on the right shoulder and pain at the right lower ribs 12/10/11.

&lt;!--StartFragment--&gt; I am 58 female and about to start Etoricoxib 60mg. My doctor prescribed this mediation for my lower back and left thigh pain. I am in US and my doctor is in India. I am supposed to take 1 pil

I am 12 weeks pregnant and last night i felt a pain on my lower right stomach trying to change the position i was sleeping and it was uncormfotable and very painful that i even screamed a little and after 2 minutes or so it went away and fa

<strong></strong><span style='text-decoration: underline;'>the appendix is on the lower rightpart of your torso

When I press down on my stomach, in the lower right side in the pelvic region it hurts. Right by my hip bone. This has been going on for about a week. Could this be really bad? Im scared that I could be pregnant. but i dont think

Since starting champix i have experienced severral side effects including: -increased urination -lower back pain -extreme fatigue -mood swings -decrease in sex drive

' i am in so much pain in my lower stomas I can hardly walk.' Feel the same thing,like a pms

11 month old developed cough and petechiae 1 week after Hib vaccination (isolated to lower abdomen). Thought this was viral until he recieved polio and HepB 1 month later (1 year) and developed petechiae again this time all over abdomen and back, and

64 years old. Good health, high BP extreme tension stress from work. Started lisinopril didn't lower BP, changed to Bystolic 10mg, lowered BP quickly, Constantly tired feeling, vey dizzy mostly in the morning constant coughing up mucus, lungs clear

Lower Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension
Condition: Otitis Externa
Interventions: Drug: Cipro HC;   Drug: Ciprofloxacin HCl and Hydrocortisone
Outcome Measures: Cure (reduced pain, swelling and otorrhea);   Identification of possible side effects
2 Recruiting Ciprofloxacin for Prevention of BK Infection
Condition: BK Virus Infection
Interventions: Drug: Ciprofloxacin;   Drug: placebo
Outcome Measures: BK infection at 6 months post-transplant;   Incidence of urinary tract infections as defined by a midstream urine sample containing 10^4 or more colony-forming units per mL;   Incidence of bacteremic infections at 6 months. Incidence of bacteremia as defined by a single positive blood culture that was not thought to be contaminated.;   Incidence of quinolone-resistant bacterial infections;   Incidence of clostridium difficile infection;   Serious adverse events;   Time to BK infection;   Proportion of patients developing BK infection at 1 year;   First and peak plasma viral loads;   Incidence of acute rejection at 1 year;   Incidence and severity of BK nephropathy, as defined by positive staining of histopathological specimen, at 1 year
3 Recruiting Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Condition: Bronchiectasis
Interventions: Drug: Ciprofloxacin: administered for 28 days on / 28 days off;   Drug: Placebo: administered for 28 days on / 28 days off;   Drug: Ciprofloxacin: administered for 14 days on / 14 days off;   Drug: Placebo: administered for 14 days on / 14 days off
Outcome Measures: Time to first exacerbation;   Mean number of exacerbations per patient per 48 weeks;   Pathogens present at baseline and eradicated at 48 weeks;   Quality of Life: Changes of Saint George's Respiratory;   New pathogens at 48 weeks, not present at baseline;   Changes of Forced Expiratory Volume in 1 second from baseline;   Number of participants with Adverse events as a measure of
4 Recruiting Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention
Condition: Adverse Reaction to Other Drugs and Medicines
Interventions: Drug: Norfloxacin;   Drug: Ciprofloxacin
Outcome Measures: The prevention rate of spontaneous bacterial peritonitis (SBP);   1 year mortality;   Incidence of infectious event other than SBP;   Hepatorenal syndrome;   Hepatic encephalopathy;   Adverse event of drugs
5 Recruiting Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Condition: Bronchiectasis
Interventions: Drug: Ciprofloxacin DPI (BAYQ3939);   Drug: Placebo
Outcome Measures: Time to first exacerbation;   Mean number of exacerbations per patient per 48 weeks;   Pathogens present at baseline and eradicated at 48 weeks;   Changes of Saint George's Respiratory Questionnaire score from baseline to 48 weeks;   New pathogens at 48 weeks, not present at baseline;   Changes of Forced expiratory volume in 1 second from baseline to 48 weeks;   Number of participants with Adverse events as a measure of safety and tolerability
6 Recruiting Population Pharmacokinetics of Anti-infectious Drugs in Children
Conditions: Pediatrics;   Ceftazidime;   Ciprofloxacin;   Voriconazole
Interventions: Drug: Ceftazidime;   Drug: Ciprofloxacin;   Drug: Voriconazole
Outcome Measures: Population pharmacokinetic parameters and factors explaining variability;   Covariability factors explaining the variability (age, biological data, pharmacokinetics factors, associated treatments...)
7 Recruiting Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes
Condition: Otitis Media in Patients With Tympanostomy Tubes.
Interventions: Drug: Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension;   Drug: CIPRODEX® (Ciprofloxacin 0.3%/dexamethasone 0.1%);   Drug: Placebo Sterile Otic Suspension
Outcome Measures: Clinical Success;   Cessation of Otorrhea
8 Unknown  TINN Pharmacokinetics (PK) Study Treat Infections iN Neonates
Condition: Pharmacokinetics of Ciprofloxacin in Neonates
Intervention: Procedure: Collection of biological samples
Outcome Measures: Ciprofloxacin plasma concentration and population pharmacokinetic (PK) parameters;   PK variables;   Tolerability;   Safety;   Clinical/microbiological outcomes
9 Not yet recruiting Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects
Conditions: Healthy Volunteers;   Non-smokers
Interventions: Drug: Pracinostat;   Drug: Itraconazole;   Drug: Ciprofloxacin
Outcome Measures: Peak plasma concentration Cmax in healthy nonsmoking subjects given a single-dose of pracinostat;   Number of participants with Adverse Events as a measure of safety and tolerability of single-dose pracinostat when administered with itraconazole or with Ciprofloxacin in healthy nonsmoking adult subjects.;   Peak plasma PK concentration Area Under the Curve (AUC)AUC 0-t, AUC 0-inf in healthy nonsmoking subjects given a single dose of pracinostat
10 Recruiting A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans
Condition: Plague
Interventions: Drug: Ciprofloxacin;   Drug: doxyxcycline
Outcome Measures: all cause mortality;   time to defervesence;   antimicrobial associated adverse events
11 Recruiting Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy
Condition: Urinary Tract Infections
Interventions: Drug: Fosfomycin 3 g;   Drug: Ciprofloxacin 500 mg
Outcome Measures: Bacteriuria;   Urinary Tract Infection;   Sepsis;   Pathogens present in urine and antimicrobial resistance;   Bacteremia;   Hematuria;   Hemospermia;   Rectal bleeding;   Urinary retention;   Difficulty for miction;   Genitourinary infections associated to fever (>38ºC);   Number of participants with adverse events
12 Recruiting A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
Condition: Otitis Externa
Interventions: Drug: Ciprofloxacin/Dexamethasone;   Drug: Ciprodex (R);   Drug: Placebo
Outcome Measures: Clinical Success;   Resolution of Symptoms
13 Recruiting Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis
Condition: Non Cystic Fibrosis Bronchiectasis
Intervention: Drug: Ciprofloxacin
Outcome Measures: Time to first exacerbation;   Number of exacerbations
14 Unknown  Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Condition: Febrile Neutropenia
Interventions: Drug: Ciprofloxacin;   Drug: cefepime
Outcome Measures: Treatment efficacy;   Toxicity
15 Recruiting Antibiotics and Hydroxychloroquine in Crohn's
Condition: Crohn's Disease
Interventions: Drug: Ciprofloxacin;   Drug: Doxycycline;   Drug: Hydroxychloroquine;   Drug: Budesonide
Outcome Measures: • Remission, defined as Crohn's Disease activity index (CDAI) <150 at 10 weeks without addition of any other medication or treatment for the Crohn's Disease.;   • Remission, defined as CDAI ≤150 maintained through to 24 weeks;   • Remission, defined as CDAI ≤150 maintained through to 52 weeks;   • Remission defined as CDAI <150 at 4 weeks;   • Response defined as a fall in CDAI by >70 points at 4 weeks and 10 weeks;   • Markers of cost (days admitted to hospital, days unable to carry out normal daily activities, need for surgery);   • Quality of life at 4 weeks, at 10 weeks, or Early Withdrawal;   • Patient global assessment of symptom severity by 10 cm visual analogue score at 4 weeks, at 10 weeks, or Early Withdrawal;   • Adverse Events and possible drug-related side effects: nausea, diarrhoea, mood disturbance, sleep disturbance - will all be assessed at each visit;   • Fall in Faecal Calprotectin
16 Recruiting Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
Condition: Traveler's Diarrhea
Interventions: Drug: Rifamycin SV MMX;   Drug: Ciprofloxacin
Outcome Measures: Time to Last Unformed Stool (TLUS);   Clinical cure
17 Recruiting Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
Conditions: SBP;   Liver Cirrhosis
Interventions: Drug: Cefotaxime;   Drug: Ceftriaxone;   Drug: Ciprofloxacin
Outcome Measures: Infection resolution rates within 5 days of treatment;   Infection resolution rates within 5 days;   Mortality & recurrence rates within 1 month
18 Recruiting BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
Conditions: HIV;   Salivary Gland Disease;   Benign Lymphoepithelial Lesion
Interventions: Drug: Ciprofloxacin;   Drug: Placebo
Outcome Measures: (BK) Virus replication and shedding;   Salivary function
19 Recruiting Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
Conditions: Urinary Tract Infections;   Acute Pyelonephritis
Interventions: Drug: Finafloxacin 800 mg i.v. once daily;   Drug: Finafloxacin placebo i.v. once daily;   Drug: Finafloxacin 800 mg tablets (as four 200 mg tablets) once daily;   Drug: Finafloxacin placebo tablets (as four tablets) once daily;   Drug: Ciprofloxacin 400 mg i.v. two times daily;   Drug: Ciprofloxacin placebo i.v. two times daily;   Drug: Ciprofloxacin 500 mg oral (as two 250 mg capsules) two times daily;   Drug: Ciprofloxacin placebo oral (as two capsules each) two times daily
Outcome Measures: Clinical and microbiological response of patients with cUTI or pyelonephritis.;   The clinical and microbiological response at the On Therapy (OT) visit (Day 3).;   The clinical and microbiological response at the End of Therapy (EoT) visit (Day 10).;   The clinical and microbiological response at the End of Study (EoS) visit (Day 24).;   The safety and tolerability of multiple doses of finafloxacin of both 5 days and 10 days of treatment with finafloxacin (i.v. and oral) in subjects with cUTI, compared to 10 days of Ciprofloxacin (i.v. and oral).;   The predictive capacity of PK/PD data of both 5 days and 10 days of treatment with finafloxacin (i.v. and oral) in subjects with cUTI, using 10 days of Ciprofloxacin (i.v. and oral) as reference on clinical outcomes (EMA guidance).
20 Recruiting Antibiotic Prophylaxis in Laparoscopic Cholecystectomy
Condition: Cholelithiasis
Interventions: Drug: Ciprofloxacin;   Drug: Ampicillin-sulbactam;   Drug: Placebo
Outcome Measures: Surgical site infection;   Extra-abdominal infections;   Adverse events.;   Quality of life